Skip to main content
PCVX logo

PCVX · Vaxcyte, Inc. · Analyst Estimates

Track PCVX — free
$60.16 +1.64 (+2.80%) Play latest call Q4 2025 earnings call transcript
Market Cap
$9.26B
Shares
158.30M
Volume · Nov 19 172.87K Avg daily vol (3M) 2.16M

Analyst Estimates

Compare analyst forecasts for Vaxcyte, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-18 22:30 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-8.62
-7.87
-7.18
7
-8.14
-8.53
-8.20
-8.20
— —
4
4
Revenue
USD
Publication date not stated
0.00
0.00
0.00
9
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-9.56
-6.87
-4.52
7
-7.12
-7.53
-7.22
-7.22
1
1
4
4
Revenue
USD
Publication date not stated
0.00
0.00
0.00
9
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-2.35
-1.92
-1.31
7
-1.96
-2.25
-2.05
-2.05
— —
4
4
Revenue
USD
Publication date not stated
0.00
0.00
0.00
8
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-2.00
-1.66
-0.97
3
-1.54
-1.32
-1.32
-1.32
— —
1
1
Revenue
USD
Publication date not stated
0.00
0.00
0.00
5
— — — — — — — —
Key facts CIK 1649094 CUSIP 92243G108 13F (30d) 372 filings 338 filers Visit website Investor relations